ERBB2 and metastatic neoplasm: Briefly, when analyzing the IHC characteristics, we observed that ER and/or PgR were more commonly expressed in patients with HER2 status discordance between the early and metastatic disease compared to patients with concordant HER2 status (p < 0.0001 and p = 0.006, for ER and PgR, respectively).